Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3973920013 | Pemigatinib 4.5 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3973921012 | Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only pemigatinib in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Pemigatinib | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 4.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely pemigatinib 4.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Pemigatinib | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets